#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
proLékaře.cz / Journals / Transfusion and Haematology Today / 2012 - 1

The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

Czech version

Authors: O. Hrodek
Published in: Transfuze Hematol. dnes,18, 2012, No. 1, p. 49.
Category: Selection of press reports and books

Labels
Haematology Internal medicine Clinical oncology
Mobilization of hematopoetic stem cells using plerixafor - experience of the Czech Republic transplantation centers
Genetic polymorphisms of platelet receptors in young patients with AIM and resistance to antiplatelet therapy
Venous thrombosis in children with acute lymphoblastic leukaemia
Prevalence of red blood cell and HLA antibodies in multi-transfused haematological patients
The role of physical activity in patients suffering from haematological malignancies
Asymptomatic pituitary macroadenoma oppressing optic chiasm – ‘incidentaloma‘ – identified within diagnostical staging of patient with primary extranodal diffuse large B-cell lymphoma of orbit and paranasal sinuses – a case report
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease
Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol
Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leukemia as examples (Perspectives)
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimérism after allogeneic stem cell transplantation
Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E. coli asparaginase: a retrospective analysis within the ALL-BFM trials
Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility (Evidence-based focused review)
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia
Article was published in

Transfusion and Haematology Today

Issue 1
2012 Issue 1
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#